146 related articles for article (PubMed ID: 10150187)
21. Antiplatelet drugs in cardiovascular diseases.
Weston C; Rao U
Int J Clin Pract; 2003 Dec; 57(10):898-905. PubMed ID: 14712893
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological prevention of atherothrombotic events in patients with peripheral arterial disease.
Blinc A; Poredos P
Eur J Clin Invest; 2007 Mar; 37(3):157-64. PubMed ID: 17359482
[TBL] [Abstract][Full Text] [Related]
23. Antiplatelet drugs in cardiovascular prevention: coronary events and stroke: primary prevention.
Prescrire Int; 2000 Jun; 9(47):89-90. PubMed ID: 11010752
[TBL] [Abstract][Full Text] [Related]
24. [Trapidil after one year].
Agus GB
Minerva Cardioangiol; 1993 May; 41(5):159-66. PubMed ID: 8373465
[TBL] [Abstract][Full Text] [Related]
25. Antiplatelet drug resistance: not ready for prime time.
Burns TL; Mooss AN; Hilleman DE
Pharmacotherapy; 2005 Nov; 25(11):1621-8. PubMed ID: 16232023
[TBL] [Abstract][Full Text] [Related]
26. Variability in responsiveness to clopidogrel in patients with intermittent claudication.
Cassar K; Bachoo P; Ford I; Greaves M; Brittenden J
Eur J Vasc Endovasc Surg; 2006 Jul; 32(1):71-5. PubMed ID: 16549375
[TBL] [Abstract][Full Text] [Related]
27. The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease.
Mehta SR; Yusuf S;
Eur Heart J; 2000 Dec; 21(24):2033-41. PubMed ID: 11102254
[TBL] [Abstract][Full Text] [Related]
28. High prevalence of previous antiplatelet drug use in patients with new or recurrent ischemic stroke: Buffalo metropolitan area and Erie County stroke study.
Qureshi AI; Kirmani JF; Safdar A; Ahmed S; Sayed MA; Pande RU; Ferguson R; Hershey LA; Qazi KJ
Pharmacotherapy; 2006 Apr; 26(4):493-8. PubMed ID: 16553507
[TBL] [Abstract][Full Text] [Related]
29. Peripheral arterial disease: a review of disease awareness and management.
Watson K; Watson BD; Pater KS
Am J Geriatr Pharmacother; 2006 Dec; 4(4):365-79. PubMed ID: 17296541
[TBL] [Abstract][Full Text] [Related]
30. Sirolimus for below the knee lesions: mid-term results of SiroBTK study.
Commeau P; Barragan P; Roquebert PO
Catheter Cardiovasc Interv; 2006 Nov; 68(5):793-8. PubMed ID: 17039538
[TBL] [Abstract][Full Text] [Related]
31. Antiplatelet therapy after endovascular intervention: does combination therapy really work and what is the optimum duration of therapy?
Milani RV
Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S7-S11. PubMed ID: 19213064
[TBL] [Abstract][Full Text] [Related]
32. Anti-platelet therapy: is it all over in peripheral artery disease?
Jaipersad AS; Silverman SH; Lip GY
Thromb Haemost; 2010 Apr; 103(4):689-91. PubMed ID: 20174749
[No Abstract] [Full Text] [Related]
33. Clinical use of antiplatelet therapy.
Balsano F; Violi F
Haematologica; 1989; 74(3):325-9. PubMed ID: 2511106
[TBL] [Abstract][Full Text] [Related]
34. Masterclass series in peripheral arterial disease. Antiplatelet therapy for peripheral arterial disease and claudication.
Hiatt WR; Krantz MJ
Vasc Med; 2006 Feb; 11(1):55-60. PubMed ID: 16669416
[TBL] [Abstract][Full Text] [Related]
35. Rationale for the use of drugs inhibiting platelet function in claudicating patients with atherosclerotic leg arteries.
Verstraete M
Agents Actions Suppl; 1984; 15():173-87. PubMed ID: 6091423
[No Abstract] [Full Text] [Related]
36. [Platelet antiaggregants in other pathologies].
Jouve R
Rev Prat; 1989 Nov; 39(25):2241-3. PubMed ID: 2688045
[TBL] [Abstract][Full Text] [Related]
37. [Effect of calciparine in the mid-term treatment of peripheral arteriopathy of the lower extremities].
Stanzani M; Colombo L; Altomare S; Pagnozzi G; Barbieri C; Bruschi R; Pietrasanta E
Minerva Cardioangiol; 1993 Oct; 41(10):465-8. PubMed ID: 8302443
[TBL] [Abstract][Full Text] [Related]
38. [Medical treatment of sclerotic arteriopathies of the lower limbs].
Boissier C; Perrot S; Conchonnet P; Guilmot JL
Rev Prat; 1995 Jan; 45(1):63-7. PubMed ID: 7725011
[TBL] [Abstract][Full Text] [Related]
39. A critical review of antiplatelet treatment in peripheral arterial disease.
Violi F; Hiatt W
Intern Emerg Med; 2007 Jun; 2(2):84-7. PubMed ID: 17634816
[TBL] [Abstract][Full Text] [Related]
40. Antiplatelet therapy in atherosclerotic cardiovascular disease.
Gonzalez ER
Clin Ther; 1998; 20 Suppl B():B18-41. PubMed ID: 9589829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
